Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
PGNY

PGNY - Progyny Inc Stock Price, Fair Value and News

25.73USD-0.98 (-3.67%)Market Closed

Market Summary

PGNY
USD25.73-0.98
Market Closed
-3.67%

PGNY Stock Price

View Fullscreen

PGNY RSI Chart

PGNY Valuation

Market Cap

2.5B

Price/Earnings (Trailing)

40

Price/Sales (Trailing)

2.21

EV/EBITDA

28.32

Price/Free Cashflow

12.87

PGNY Price/Sales (Trailing)

PGNY Profitability

EBT Margin

6.94%

Return on Equity

10.72%

Return on Assets

7.71%

Free Cashflow Yield

7.77%

PGNY Fundamentals

PGNY Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

7.62%

Rev. Growth (Qtr)

3.01%

PGNY Earnings

Earnings (TTM)

61.3M

Earnings Growth (Yr)

-4.41%

Earnings Growth (Qtr)

25.45%

Breaking Down PGNY Revenue

Last 7 days

-8.5%

Last 30 days

-8.4%

Last 90 days

-29.6%

Trailing 12 Months

-33.9%

How does PGNY drawdown profile look like?

PGNY Financial Health

Current Ratio

3.31

PGNY Investor Care

Shares Dilution (1Y)

0.86%

Diluted EPS (TTM)

0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.1B000
2023873.1M957.5M1.0B1.1B
2022550.7M617.1M700.1M786.9M
2021386.0M450.0M473.4M500.6M
2020263.5M271.9M309.7M344.9M
2019130.3M160.3M193.7M229.7M
201862.8M77.0M91.2M105.4M
201700048.6M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Progyny Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 23, 2024
payson norman
sold
-11,258
56.29
-200
-
Jun 03, 2024
sturmer michael e
sold (taxes)
-12,073
26.95
-448
president
Jun 03, 2024
livingston mark s.
sold (taxes)
-70,528
26.95
-2,617
chief financial officer
May 28, 2024
livingston mark s.
sold (taxes)
-6,048
27.00
-224
chief financial officer
May 28, 2024
sturmer michael e
sold (taxes)
-215,379
27.00
-7,977
president
May 28, 2024
swartz allison
sold (taxes)
-36,504
27.00
-1,352
evp, gc
May 23, 2024
payson norman
acquired
-
-
6,176
-
May 23, 2024
seidenberg beth c
acquired
-
-
7,206
-
May 23, 2024
park jeffrey g
acquired
-
-
6,176
-
May 23, 2024
scott cheryl
acquired
-
-
5,147
-

1–10 of 50

Which funds bought or sold PGNY recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
added
8.00
-192
2,597
-%
Jun 04, 2024
DekaBank Deutsche Girozentrale
reduced
-94.74
-2,878,000
164,000
-%
May 30, 2024
CAMBRIDGE TRUST CO
new
-
95,375
95,375
-%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
25,000
962,000
0.01%
May 24, 2024
Cetera Investment Advisers
added
118
343,387
619,709
-%
May 24, 2024
FARALLON CAPITAL MANAGEMENT LLC
new
-
22,607,700
22,607,700
0.10%
May 20, 2024
CIM, LLC
added
0.89
7,259
362,845
0.06%
May 16, 2024
AWM Investment Company, Inc.
reduced
-54.55
-1,091,150
953,750
0.12%
May 16, 2024
COMERICA BANK
added
5.35
192,972
2,576,910
0.01%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-30.16
-712,480
1,801,560
-%

1–10 of 44

Are Funds Buying or Selling PGNY?

Are funds buying PGNY calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PGNY
No. of Funds

Unveiling Progyny Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
kleiner perkins caufield & byers xiii, llc
5.3%
5,074,615
SC 13G/A
Feb 14, 2024
macquarie group ltd
1.54%
1,481,588
SC 13G/A
Feb 13, 2024
tpg gp a, llc
7.2%
6,903,267
SC 13G/A
Feb 13, 2024
vanguard group inc
8.63%
8,270,153
SC 13G/A
Jan 23, 2024
blackrock inc.
12.6%
12,111,570
SC 13G/A
Feb 14, 2023
macquarie group ltd
5.37%
4,988,789
SC 13G/A
Feb 14, 2023
alger associates inc
2.6%
2,372,711
SC 13G/A
Feb 10, 2023
tpg gp a, llc
10.5%
9,815,351
SC 13G/A
Feb 09, 2023
vanguard group inc
7.91%
7,345,124
SC 13G/A
Jan 06, 2023
blackrock inc.
10.1%
9,346,854
SC 13G/A

Recent SEC filings of Progyny Inc

View All Filings
Date Filed Form Type Document
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
May 30, 2024
4
Insider Trading
May 30, 2024
4
Insider Trading
May 30, 2024
4
Insider Trading
May 29, 2024
8-K
Current Report
May 28, 2024
4
Insider Trading
May 28, 2024
4
Insider Trading
May 28, 2024
4
Insider Trading
May 28, 2024
4
Insider Trading

Peers (Alternatives to Progyny Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
442.8B
379.5B
-8.29% 4.94%
28.83
1.17
12.96% -25.81%
95.0B
206.0B
-1.22% 24.45%
24.66
0.46
12.55% -43.95%
89.2B
66.7B
5.52% 17.44%
16.31
1.34
9.59% -4.59%
76.6B
360.9B
5.79% -9.89%
10.45
0.21
9.07% 78.83%
35.4B
155.5B
-14.95% 1.11%
12.95
0.23
6.34% 84.42%
12.8B
14.7B
7.24% 28.23%
15.69
0.87
7.99% 19.23%
12.5B
12.3B
1.72% 45.70%
15.29
1.01
5.77% 58.74%
MID-CAP
8.0B
2.3B
-5.98% -2.73%
28.37
3.51
5.96% 18.29%
6.3B
3.0B
2.95% -6.62%
-560.88
2.12
10.92% -104.06%
2.3B
1.5B
2.33% 34.16%
37.47
1.61
19.34% 40.15%
2.0B
3.5B
-10.43% -51.38%
13.88
0.57
-27.67% -62.40%
SMALL-CAP
2.0B
1.1B
7.81% 29.94%
29.74
1.8
11.45% 30.74%
1.3B
3.0B
-4.49% 62.56%
-7.32
0.42
4.98% 4.88%
59.8M
-
9.66% -15.93%
-3.96
-
- -1.05%
20.4M
21.6M
-5.85% 24.81%
40.12
0.94
9.04% -57.88%

Progyny Inc News

Latest updates
Defense World24 hours ago
InvestorPlace10 May 202407:00 am

Progyny Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue3.0%27827028127925821420519517212812212912210099.0065.0081.0065.0061.0056.0047.00
Gross Profit9.7%62.0057.0063.0061.0059.0044.0046.0044.0033.0025.0028.0030.0029.0021.0021.0012.0017.0012.0012.0011.0010.00
Operating Expenses1.8%44.0043.0044.0045.0044.0041.0035.0035.0033.0025.0019.0018.0017.0020.0016.0013.0013.0011.009.009.007.00
  S&GA Expenses3.6%15.0015.0015.0015.0014.0013.0011.0011.0010.008.004.004.004.005.003.004.003.003.003.003.002.00
EBITDA Margin6.2%0.07*0.07*0.06*0.06*0.05*0.03*0.03*0.03*0.04*0.07*0.08*0.07*---------
Interest Expenses-14.8%1.001.001.001.001.001.000.000.000.000.000.000.00-0.02-0.02-0.020.000.000.00-0.03-0.13-0.04
Income Taxes101.2%6.003.005.002.00-1.301.00-1.670.00-5.11-15.48-7.68-6.81-3.37-37.900.00-0.020.00-0.080.000.00-
Earnings Before Taxes38.5%23.0016.0021.0017.0016.004.0012.009.00-0.14-0.409.0012.0012.001.005.00-1.064.00-4.48-8.182.003.00
EBT Margin6.8%0.07*0.06*0.06*0.05*0.05*0.03*0.03*0.03*0.04*0.06*0.07*0.07*---------
Net Income25.4%17.0013.0016.0015.0018.003.0013.009.005.0015.0017.0019.0015.0039.005.00-1.064.00-4.40-8.212.003.00
Net Income Margin-3.0%0.06*0.06*0.05*0.05*0.05*0.04*0.06*0.07*0.10*0.13*0.19*0.17*---------
Free Cashflow-32.7%25.0037.0053.0075.0020.0051.0020.0019.00-12.058.0023.00-7.90---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32018Q4
Assets5.0%79475772768265054351046341635833731229525420217818015073.0041.00
  Current Assets6.4%68264061156152743440235630925925423822819018516016213253.0025.00
    Cash Equivalents18.2%11597.0015817115512073.0055.0039.0091.0092.0049.0030.0070.0054.0049.0092.0080.008.000.00
  Net PPE0.2%10.0010.0010.009.009.008.007.006.006.005.005.004.004.003.004.004.004.003.001.001.00
  Goodwill0%12.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.00
Liabilities9.6%22320321121222516616415213610611310811087.0075.0058.0059.0036.0058.0030.00
  Current Liabilities10.7%20618619319420716015714512999.0010499.0010178.0074.0058.0059.0036.0058.0030.00
Shareholder's Equity3.3%572553515469424377347311280252224205185167126119119114--
  Retained Earnings18.8%10790.0077.0061.0046.0028.0025.0011.003.00-2.42-17.50-34.30-53.03-68.19-105-111-109-113-109-104
  Additional Paid-In Capital6.0%48946243840937935032330127825524324023923623423223222919.0011.00
Shares Outstanding-0.2%96.0096.0096.0095.0094.0093.0092.0092.0091.0089.0090.0088.00--------
Float----3,300---2,300---4,100---1,100-1,100--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-31.7%25,73237,65954,18276,01220,96151,51720,89419,246-11,2628,81524,163-7,4735326,53715,3292,19712,140-5,4895,8794,247-6,171
  Share Based Compensation7.8%31,05228,79931,25131,75330,80829,29723,29723,65424,50015,0087,1476,5175,0344,1603,0713,5412,0491,8521,6801,012517
Cashflow From Investing120.7%19,344-93,414-64,315-58,92316,127-1,173-1,876-1,259-39,558-6,31222,37431,224-38,52011,887-9,148-42,077-693-2,278-420-13375.00
Cashflow From Financing-445.5%-27,411-5,025-2,362-1,839-1,846-2,786-1,228-2,078-1,772-3,314-3,060-4,824-2,497-2,084-1,608-2,363-19480,4851,907-4,1806,333
  Buy Backs-23,764----------------3.00---
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

PGNY Income Statement

2024-03-31
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statements of Operations  
Revenue$ 278,078$ 258,394
Cost of services215,672199,754
Gross profit62,40658,640
Operating expenses:  
Sales and marketing15,45414,282
General and administrative28,42929,347
Total operating expenses43,88343,629
Income from operations18,52315,011
Other income, net:  
Other income, net3,360498
Interest income, net632822
Total other income, net3,9921,320
Income before income taxes22,51516,331
Provision (benefit) for income taxes5,617(1,347)
Net income$ 16,898$ 17,678
Net income per share:  
Basic (in dollars per share)$ 0.18$ 0.19
Diluted (in dollars per share)$ 0.17$ 0.18
Weighted-average shares used in computing net income per share:  
Basic (in shares)96,484,65793,832,873
Diluted (in shares)101,052,933100,166,008

PGNY Balance Sheet

2024-03-31
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 114,959$ 97,296
Marketable securities256,872273,791
Accounts receivable, net of $50,054 and $46,636 of allowances at March 31, 2024 and December 31, 2023, respectively297,209241,869
Prepaid expenses and other current assets12,47227,451
Total current assets681,512640,407
Property and equipment, net10,23410,213
Operating lease right-of-use assets17,18117,605
Goodwill11,88011,880
Deferred tax assets70,26973,120
Other noncurrent assets3,2283,395
Total assets794,304756,620
Current liabilities:  
Accounts payable130,171125,426
Accrued expenses and other current liabilities75,74860,524
Total current liabilities205,919185,950
Operating lease noncurrent liabilities16,78117,241
Total liabilities222,700203,191
Commitments and Contingencies (Note 6)
STOCKHOLDERS' EQUITY  
Common stock, $0.0001 par value; 1,000,000,000 shares authorized; $96,839,393 and 96,348,522 shares issued; 96,115,816 and 96,348,522 shares outstanding at March 31, 2024 and December 31, 2023, respectively99
Additional paid-in capital489,343461,639
Treasury stock, at cost, $0.0001 par value; 1,339,557 and $615,980 shares at March 31, 2024 and December 31, 2023, respectively(27,367)(1,009)
Accumulated earnings106,86989,971
Accumulated other comprehensive income2,7502,819
Total stockholders’ equity571,604553,429
Total liabilities and stockholders’ equity$ 794,304$ 756,620
PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
 CEO
 WEBSITEprogyny.com
 INDUSTRYHealthcare Plans
 EMPLOYEES393

Progyny Inc Frequently Asked Questions


What is the ticker symbol for Progyny Inc? What does PGNY stand for in stocks?

PGNY is the stock ticker symbol of Progyny Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Progyny Inc (PGNY)?

As of Tue Jun 18 2024, market cap of Progyny Inc is 2.45 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PGNY stock?

You can check PGNY's fair value in chart for subscribers.

What is the fair value of PGNY stock?

You can check PGNY's fair value in chart for subscribers. The fair value of Progyny Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Progyny Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PGNY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Progyny Inc a good stock to buy?

The fair value guage provides a quick view whether PGNY is over valued or under valued. Whether Progyny Inc is cheap or expensive depends on the assumptions which impact Progyny Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PGNY.

What is Progyny Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jun 18 2024, PGNY's PE ratio (Price to Earnings) is 40 and Price to Sales (PS) ratio is 2.21. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PGNY PE ratio will change depending on the future growth rate expectations of investors.